Phase NA × Recruiting × Leukemia, Myeloid, Acute × Clear all Massage Impact on Sleep in Pediatric Oncology
Phase NA Recruiting
70 enrolled
A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
Phase NA Recruiting
30 enrolled
SICP RCT
Phase NA Recruiting
207 enrolled
UR-GOAL RCT
Phase NA Recruiting
1,020 enrolled
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Phase NA Recruiting
200 enrolled
EUREKA-VEN
Phase NA Recruiting
100 enrolled
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Phase NA Recruiting
120 enrolled
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Phase NA Recruiting
50 enrolled
The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment
Phase NA Recruiting
60 enrolled
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
Phase NA Recruiting
50 enrolled
Q-TRANS
Phase NA Recruiting
52 enrolled
LAMME
Phase NA Recruiting
30 enrolled
Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation
Phase NA Recruiting
36 enrolled
GATA-2
Phase NA Recruiting
150 enrolled
Home Blood Transfusions
Phase NA Recruiting
30 enrolled
PTX3AML
Phase NA Recruiting
410 enrolled
LUCID
Phase NA Recruiting
910 enrolled
Maintenance Venetoclax in AML Fit Patients
Phase NA Recruiting
80 enrolled
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
Phase NA Recruiting
43 enrolled
NAVIGATE
Phase NA Recruiting
200 enrolled
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Phase NA Recruiting
325 enrolled
Ven-BUCY
Phase NA Recruiting
138 enrolled
MRD-positive AML Clinical Study
Phase NA Recruiting
120 enrolled
Venetoclax-Decitabine in Untreated Elderly/Unfit AML
Phase NA Recruiting
39 enrolled
Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
Phase NA Recruiting
184 enrolled
ACT
Phase NA Recruiting
920 enrolled
SCOPE-L
Phase NA Recruiting
2,300 enrolled
HOME-BLOOD
Phase NA Recruiting
15 enrolled
Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy
Phase NA Recruiting
90 enrolled
BAIT
Phase NA Recruiting
60 enrolled
MTSA
Phase NA Recruiting
21 enrolled
Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
Phase NA Recruiting
22 enrolled
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
Phase NA Recruiting
40 enrolled
SHARP
Phase NA Recruiting
51 enrolled
Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
Phase NA Recruiting
157 enrolled
Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy
Phase NA Recruiting
83 enrolled
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
Phase NA Recruiting
100 enrolled
AL-TOMICA
Phase NA Recruiting
100 enrolled
Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
Phase NA Recruiting
50 enrolled
MRD Response-adapted Allo-HSCT for Adverse-risk AML
Phase NA Recruiting
178 enrolled
Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test
Phase NA Recruiting
60 enrolled
PHOTO-TREAT
Phase NA Recruiting
30 enrolled
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
Phase NA Recruiting
78 enrolled
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
Phase NA Recruiting
34 enrolled
The Maintenance Treatment of "ITIVA" in AML Patients
Phase NA Recruiting
130 enrolled
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
Phase NA Recruiting
54 enrolled
Novel Approaches to Target MECOM/EVI1 in AML
Phase NA Recruiting
24 enrolled
A Study of Chidamide With AZA in MRD Positive AML After Transplant
Phase NA Recruiting
60 enrolled
Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission
Phase NA Recruiting
100 enrolled
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
Phase NA Recruiting
20 enrolled